<DOC>
	<DOCNO>NCT01052987</DOCNO>
	<brief_summary>This randomize , double-blind , 3-period 3-treatment crossover follow 2-period 2-treatment crossover , phase 2 study patient document hyperuricemia evaluate effect tranilast allopurinol pharmacokinetics ( PK ) pharmacodynamics ( PD ) evaluate effect allopurinol tranilast PK PD measure reduction serum uric acid level .</brief_summary>
	<brief_title>Study Tranilast Alone Combination With Allopurinol Subjects With Hyperuricemia</brief_title>
	<detailed_description />
	<mesh_term>Hyperuricemia</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<mesh_term>Tranilast</mesh_term>
	<criteria>Male female , age 21 70 Subjects hyperuricemia otherwise healthy Pregnant nursing Known history gout unless approve Investigator Sponsor Clinically significant infection Screening Known sensitivity tranilast allopurinol</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Gout</keyword>
	<keyword>Hyperuricemia</keyword>
</DOC>